Drosophila offers many advantages for the detection of mutagenic activity of carcinogenic agents. It provides the quickest assay system for detecting mutations in animals today. Its generation time is short, and Drosophila is cheap and easy to breed in large numbers. The simple genetic testing methods give unequivocal answers about the whole spectrum of relevant genetic damage. A comparison of the detection capacity of assays sampling different kinds of genetic damage revealed that various substances are highly effective in inducing mutations but do not produce chromosome breakage effects at all, or only at much higher concentrations than those required for mutation induction. Of the different assay systems available, the classical sex-linked recessive lethal test deserves priority, in view of its superior capacity to detect mutagens. Of practical importance is also its high sensitivity, because a large number of loci in one fifth of the genome is tested for newly induced forward mutations, including small deletions.
Introduction
Recent results with microbial assay systems, such as the Ames test with Salmonella, have demonstrated a striking overlap between carcinogenicity and mutagenicity. That is, the great majority of compounds capable of producing malignant transformation are also effective in producing genetic changes in the form of heritable mutations. The possibilities the Ames test has to offer for a quick identification of potential carcinogens in the human environment is indeed a major accomplishment. Regulatory measures, with all the consequences for society, should, in our opinion, not be based on data obtained with a single assay system, but would re-*Paper presented by the senior author in a meeting of the Scientific Committee for Occupational and Environmental Health, Fondazione Carlo Erba, Instituzione Culturale Medica, Milano, Italy, December 12, 1975. tDepartment of Radiation Genetics and Chemical Mutagenesis University of Leiden, The Netherlands. quire the confirmation after the application of a battery of different test systems. Since man is more closely related to other mammals than bacteria, various authors (1,2) emphasize the importance of mammalian assay systems. From a toxicological point of view, the intact mammal obviously offers enormous advantages over many other assay systems, since information regarding pharmacokinetics, as resorption, elimination, and drug metabolism both inside and outside the target cells, can only be obtained by studies on mammals. With regard to the genetic data that can be obtained from the intact mammal, we tend to be more pessimistic, however.
From the point of view of genetic hazards, transmissible point mutations and small deletions deserve probably the highest priority (3), particularly so since the induction of these changes correlates with the risk of carcinogenesis. For the detection of this class of genetic damage one has until now to rely entirely on specific locus tests. In view of the extreme costs and labor involved, there are only a few laboratories in the world where these can be carried out. The time and cost required to collect meaningful data places severe limitations on the number of chemicals and concentrations that can be investigated. Experimentation is restricted to high concentrations, and since dose-effect curves with chemical mutagens do not exhibit simple proportionality, there is no a p7iori justification for linear extrapolation to low concentrations.
All other in vivo mammalian assay systems which can be employed for routine screening purposes rely on the detection of chromosome breakage effects, whether these are recovered from bone marrow, peripheral blood, testes, or in dominant lethal assays. Recent experiments with Drosophila have revealed that a number of substances, the indirectly-acting carcinogens in particular, are highly effective in inducing mutations but do not produce chromosome breakage effects at all or induce breakage effects only at much higher concentrations than those required for mutation induction. Such compounds thus could spuriously register as safe in any routine mammalian in vivo assay system. Since it is particularly these substances which entail the risk of producing malignancy, mammalian tests relying on chromosome breakage cannot be considered as diagnostic. Salmonella, yeast, and mammalian cell cultures with microsomal extracts or Drosophila would seem preferable.
Advantages of Drosophila as a Test System
In the light of these considerations, the possibilities afforded by Drosophila for detecting various classes of mutagens will be discussed (4) (5) (6) (7) . Among the various types of reactions catalyzed are, for example, oxidative attack of aromatic rings, C-alkyl, N-alkyl, S-alkyl, or O-alkyl groups, all fundamental steps that are well known to play a part in the bioactivation of indirect carcinogens and mutagens. Most of the more direct biochemical information is derived from studies with the housefly, Musca domestica. The evidence that Drosophila is capable of facilitating similar reactions is based on mutation studies carried out mainly by Vogel during the last few years (6) .
Some forty compounds that require metabolic activation have now been tested in Drosophila and yielded positive response for the induction of recessive lethals (see Table 1 ). First demonstration of biotransformation was obtained by Clark (8) for the pyrrolizidine alkaloid, heliotrine, and by Pasternak (9-11) for the dimethyl and diethylnitrosamines. More recently, Vogel has studied the response of Drosophila for various groups of indirectly-acting carcinogens. His data, and those of earlier studies, show that some 40 compounds falling into nine different groups, produce a positive response in tests for recessive lethal mutations with Drosophila (6). The genetic activity of these widely different substances convincingly demonstrate the versatility and lack of substrate specificity of the Drosophila enzyme In the studies on the mode of action of indirect mutagens by Vogel, the application of this brooding technique has revealed the interesting observations that indirectly acting carcinogens exhibit a similar stage-specific sensitivity pattern, despite considerable differences in their mode of activation (see Fig. 1 ). That is, spermatids and spermatocytes appear to show greatest response (6, 15, 16) . Thus diethyl nitrosamine, azoxymethane, and cyclophosphamide all exhibit peak activity 4-6 days after treatment and reduced fertility after 7-9 days. From studies with the electron microscope by Tates (27) . Mutagens of this kind would be difficult to detect in any assay system in which chromosome breakage is applied as the only criterion of mutagenic activity. For dominant lethal induction in rats and mice, DEN and dimethyl sulfate (DMS), related to diethyl sulfate, were indeed ineffective (28, 29) : similarly negative results were recorded for dimethylnitrosamine (DMN) and N-nitrosomorpholine (30), though they are highly effective in producing mutations in Drosophila.
The observation that mutagens like MMS and TEB produce only chromosome aberrations at considerably higher concentrations than those required for recessive lethal induction is likewise of interest in assessing the detection capacity of various assay systems. Findings like these raise the possibility that, when assay systems relying on chromosome breakage only, as is, in fact, the case for all routine mammalian in vivo tests, whether these be dominant lethals, chromosome aberrations in bone marrow or peripheral blood, translocations or micronuclei, false negatives can be obtained, simply because the concentration at the target cells is not sufficiently high.
An indication of such phenomena has been obtained by Vogel when comparing the mutagenic 
